Luxembourg · Delayed Price · Currency is EUR · Price in USD CTI BioPharma Statistics
Total Valuation
Cipla has a market cap or net worth of EUR 12.51 billion. The enterprise value is 11.51 billion.
| Market Cap | 12.51B |
| Enterprise Value | 11.51B |
Important Dates
The last earnings date was Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | Jun 26, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 562.88M |
Valuation Ratios
The trailing PE ratio is 23.36 and the forward PE ratio is 24.88.
| PE Ratio | 23.36 |
| Forward PE | 24.88 |
| PS Ratio | 4.58 |
| PB Ratio | 4.03 |
| P/TBV Ratio | 4.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 21.49 |
| EV / Sales | 4.22 |
| EV / EBITDA | 16.18 |
| EV / EBIT | 18.80 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | n/a |
| Interest Coverage | 154.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.08% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 90,003 |
| Profits Per Employee | 17,662 |
| Employee Count | 30,313 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Cipla has paid 156.13 million in taxes.
| Income Tax | 156.13M |
| Effective Tax Rate | 22.60% |
Stock Price Statistics
The stock price has decreased by -2.73% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.73% |
| 50-Day Moving Average | 17.43 |
| 200-Day Moving Average | 17.47 |
| Relative Strength Index (RSI) | 54.96 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cipla had revenue of EUR 2.73 billion and earned 535.38 million in profits. Earnings per share was 0.66.
| Revenue | 2.73B |
| Gross Profit | 1.82B |
| Operating Income | 614.11M |
| Pretax Income | 690.80M |
| Net Income | 535.38M |
| EBITDA | 704.05M |
| EBIT | 614.11M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 1.05 billion in cash and 43.63 million in debt, giving a net cash position of 1.01 billion.
| Cash & Cash Equivalents | 1.05B |
| Total Debt | 43.63M |
| Net Cash | 1.01B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.11B |
| Book Value Per Share | 3.83 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 66.69%, with operating and profit margins of 22.51% and 19.62%.
| Gross Margin | 66.69% |
| Operating Margin | 22.51% |
| Pretax Margin | 25.32% |
| Profit Margin | 19.62% |
| EBITDA Margin | 25.81% |
| EBIT Margin | 22.51% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 0.71%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 0.71% |
| Dividend Growth (YoY) | 10.30% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.71% |
| Earnings Yield | 4.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |